-National Cancer Institute - NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas

  • Gary Schwartz

Press/Media

Period2 Apr 2018

Media coverage

1

Media coverage

  • Title-National Cancer Institute - NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas
    Media name/outletENP Newswire
    Date2/04/18
    PersonsGary Schwartz